Toradol

Basic Toradol Information

• INN (International Nonproprietary Name): Ketorolac Tromethamine.
• Brand Names Available In Canada (English): Toradol, Ketorolac.
• ATC Code: M01AB15.
• Forms & Dosages: Tablet (oral) 10 mg; Injection 10 mg/mL and 30 mg/mL; nasal spray Sprix not widely marketed; ophthalmic 0.5% (Acular) noted internationally.
• Manufacturers In Canada (English): Not specified.
• Registration Status In Canada (English): Widely registered with Rx-only status; marketed products carry a Drug Identification Number (DIN).
• OTC / Rx Classification: Prescription-only (Rx) in Canada.

Critical Warnings & Restrictions In Canada

Priority Safety Messages For Patients And Caregivers

Toradol (ketorolac tromethamine) is prescription-only in Canada and intended for short-term use only.

The maximum duration for oral or parenteral therapy is five days because of increased risks of gastrointestinal bleeding, renal injury and cardiovascular events.

Before dispensing, verify allergies to NSAIDs, active bleeding, recent peptic ulcer disease, renal impairment, or current anticoagulant use.

Pregnancy, especially the third trimester, and breastfeeding are contraindications for ketorolac.

In community settings where alternatives are reasonable, ensure informed consent and that the patient understands the five-day limit and monitoring requirements.

• Checklist For Pharmacy Counselling: Confirm NSAID allergy and prior reactions.
• Review current medications including anticoagulants and other NSAIDs.
• Ask about kidney or liver disease and recent or planned surgery.
• Confirm pregnancy status or breastfeeding.
• Document counselling and advise on signs of bleeding and kidney problems.

High‑Risk Groups

Elderly: Older adults are at higher risk of GI, renal and cardiovascular adverse events and dose reduction is advised.

Monitor renal function in elderly patients before and during treatment when possible.

Pregnancy And Breastfeeding: Ketorolac is contraindicated in the third trimester and should be avoided in pregnancy and breastfeeding unless a specialist advises otherwise.

Indigenous Health Considerations: Some Indigenous communities have higher prevalence of diabetes and chronic kidney disease.

Screen renal function and provide culturally safe counselling, involving community health workers when appropriate.

Interaction With Activities

Ketorolac can cause dizziness, drowsiness and impaired concentration.

Advise patients not to drive or operate heavy machinery until they know how Toradol affects them.

Document safety advice in the patient record and offer written counselling to support workplace safety requirements.

Q&A — “Can I Drive After Taking It In Canada?”

Short answer: Not until you know how it affects you.

If you experience dizziness, drowsiness or visual disturbance, do not drive or operate machinery.

Document the advice on the patient record and provide written counselling for the patient to keep.

Usage Basics For Canadians

INN, Brand Names Available In Canada

The International Nonproprietary Name is ketorolac tromethamine, commonly shortened to ketorolac.

Brand names in Canada include Toradol and generic ketorolac products.

Available dosage forms and strengths include:

• Oral tablets: 10 mg.
• Injectable vials/ampoules: 10 mg/mL and 30 mg/mL.
• Nasal spray Sprix and ophthalmic formulations are noted internationally but availability varies.

Legal Classification Under Health Canada

Toradol is prescription-only (Rx) across Canada.

Health Canada requires a Drug Identification Number (DIN) for marketed products and packaging will show the DIN.

Packaging for nationally distributed products often includes bilingual labelling (English/French).

Pharmacy practice note: pharmacists must confirm a valid prescription and document counselling according to provincial regulations.

Emergency supply rules and pharmacist substitution policies vary by province.

Canadian Dosing Guide

Standard Regimens (Health Canada‑Approved)

Typical adult oral dosing is 10 mg every 4–6 hours as needed.

Parenteral intramuscular or intravenous dosing commonly ranges 10–30 mg every 6 hours depending on clinical setting.

The maximum approved duration for oral and parenteral therapy is five days.

Single IM or IV 30 mg doses are sometimes used for acute indications such as severe migraine in emergency settings (off‑label use).

Adjustments For Comorbidities

Avoid or significantly reduce dose in renal impairment; ketorolac is contraindicated in severe renal failure.

Elderly patients should receive lower doses and closer monitoring of renal function.

Use caution with hepatic impairment and monitor liver function tests when appropriate.

Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”

Do not double the next dose to make up for a missed dose.

If outpatient and you miss a dose, take it as soon as you remember unless the next dose is near.

Follow prescriber or pharmacist advice for specific regimens and depend on local prescribing instructions.

Coverage and refill rules for missed doses vary by provincial plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ; check your plan’s pharmacy adjudication resources.

Interaction Chart (Canadian Context)

Food And Drink Interactions

Alcohol increases the risk of gastrointestinal bleeding when combined with NSAIDs including ketorolac.

Counsel patients to avoid or limit alcohol while taking Toradol.

Caffeine has no major direct interaction but may mask drowsiness or alter perceived alertness; advise caution.

• Do not mix ketorolac with alcohol due to bleeding risk.
• Limit alcohol intake until the course is finished and any bleeding symptoms have resolved.
• Advise patients that caffeine will not protect kidneys or prevent bleeding.

Common Drug Conflicts

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

Common patient-reported themes include rapid and strong short‑term pain relief, especially when toradol is given parenterally in emergency or hospital settings.

Patients frequently comment on fast onset after IV or IM dosing and effective control for postoperative pain.

Concerns often relate to gastrointestinal and renal side effects and questions about duration limits and access.

Cost and prescription access are recurring topics on provincial patient groups and pharmacy review pages.

Community Pharmacy Feedback

Pharmacists commonly see Toradol started in hospital and intentionally stopped at discharge because of the five‑day safety limit.

Pharmacy teams emphasise verifying renal function and anticoagulant use before dispensing for discharge prescriptions.

• Top 5 Patient Concerns: Efficacy, duration limit, bleeding risk, kidney safety, access/cost.
• Top 5 Pharmacist Checks: Indication and duration, renal function, anticoagulant/antiplatelet use, pregnancy status, documented counselling.

Report suspected serious adverse reactions such as GI bleed or acute kidney injury to Health Canada’s Canada Vigilance Program.

Access & Purchase Options

National Pharmacy Chains And In‑Store Realities

Toradol is dispensed only on prescription and is available at national chains including Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu when stocked.

Hospital pharmacies commonly supply injectable doses for inpatient use.

Outpatient supply depends on community pharmacy inventory and supplier availability.

Online Pharmacies In Canada & Provincial Restrictions

Online Canadian pharmacies require a valid prescription and must follow provincial licensing and shipping rules.

Some provinces limit emergency supplies and have specific rules on pharmacist substitution and documentation.

Cross‑border importation for personal use is legally restricted and is not recommended.

• Checklist For Patients When Purchasing: Bring a valid prescription and photo ID.
• Also bring your provincial health card and any private insurance information.
• Ask for pharmacist counselling and check that packaging includes the DIN and bilingual labelling if needed.

In our online pharmacy, Toradol is available with a valid prescription and discreet delivery to Canada in 5–14 days.

Mechanism & Pharmacology

Simplified Explanation (Patient‑Friendly)

Toradol is a non‑steroidal anti‑inflammatory drug that inhibits both COX‑1 and COX‑2 enzymes.

By reducing prostaglandin synthesis, it provides potent analgesia for moderate to severe acute pain.

It carries no dependence risk like opioids but has a short treatment window because of GI and renal safety concerns.

Clinical Terms (Health Canada Monograph References)

• ATC Code: M01AB15.
• COX‑1: An enzyme involved in gastric protection and platelet function.
• COX‑2: An enzyme largely responsible for inflammation and pain.
• DIN: Drug Identification Number assigned by Health Canada to marketed products.

Indications & Off‑Label Uses In Canada

Approved Indications (DIN)

Primary approved use is short‑term management of moderate to severe acute pain, particularly postoperative pain, in oral and parenteral forms.

Product monographs and DIN labelling guide indication‑specific dosing and the maximum five‑day duration.

Common Off‑Label Practices (Canadian Physicians)

Off‑label use can include a single IM or IV dose for severe migraine attacks in emergency departments.

Off‑label prescribing should include documentation of indication, a benefit–risk discussion and appropriate monitoring.

• Approved: Short‑term moderate to severe acute pain, postoperative analgesia.
• Off‑Label: Single parenteral dose for acute migraine in ED settings.
• Documentation Checklist: Indication, informed consent, planned duration, monitoring plan.

Key Clinical Findings

Canadian And International Studies 2022–2025

Recent studies continue to show ketorolac’s potent short‑term analgesic efficacy compared with other agents for acute postoperative pain.

Onset after IV or IM administration is rapid and may approximate the speed of opioid analgesia without dependence risk.

However, literature repeatedly highlights the heightened risks of GI bleeding and acute kidney injury, underpinning the five‑day maximum duration.

Ongoing Health Canada Safety Monitoring

Health Canada monitors safety through post‑marketing surveillance and encourages reporting of suspected serious adverse drug reactions.

Prescribers and pharmacists should report serious events such as GI bleeding, renal failure or anaphylaxis to Canada Vigilance.

Alternatives Matrix

Comparable Medicines With DIN In Canada

Alternatives include ibuprofen, naproxen, diclofenac (oral and topical), acetaminophen, and when appropriate, opioid analgesics or triptans for migraine.

Each alternative differs in potency, safety profile and whether it is available over the counter or by prescription.

Pros And Cons Checklist

Common Questions From Canadian Patients

• Can I take Toradol with acetaminophen? Yes, they are often used together for additive pain relief but check kidney and bleeding risk.
• Can my child receive it? Use in children is rare and weight‑based dosing applies; consult a specialist or paediatrician.
• Will my provincial drug plan pay? Coverage varies by province and program; check your provincial formulary or insurer.
• How long before surgery should I stop it? Inform your surgeon and stop per perioperative guidance; generally NSAIDs are stopped pre‑op as advised by the surgical team.
• How to spot GI bleeding or kidney injury? Watch for black or tarry stools, vomiting blood, reduced urine output, swelling or severe abdominal pain and seek emergency care.
• What if I take an anticoagulant? Contact the prescriber; combined use raises bleeding risk and requires specialist input.
• Can I drink alcohol while taking it? Avoid alcohol because it increases GI bleeding risk.
• What should I monitor at home? Note urine output, new swelling, severe abdominal pain, dizziness or black stool and report immediately.
• Who do I contact with concerns? Contact your pharmacist or prescriber for urgent advice and report serious reactions to Health Canada.

Call to action: Contact your pharmacist or prescriber if you have any questions or new symptoms while taking toradol.

Coverage & Purchase Comparison Table

Coverage for toradol varies by provincial formulary and patient eligibility.

Hospital inpatient supply is standard, while outpatient coverage depends on private insurance or specific provincial programs.

Step‑by‑step purchase checklist for Canadian patients:

1. Obtain a valid prescription that includes the DIN if available.
2. Check provincial formulary or private insurer coverage before filling.
3. Present photo ID and provincial health card at the pharmacy.
4. Request pharmacist counselling and written patient information.
5. Understand the five‑day maximum duration and monitoring needs.

Registration & Regulation

Health Canada Approval

Toradol and ketorolac products are registered in Canada with prescription‑only status.

Products marketed in Canada carry a Drug Identification Number and follow the Health Canada product monograph for approved indications, dosing and safety information.

DIN Number And Labelling Requirements

Each marketed product displays a DIN and lot/expiry information on the carton and package insert.

Bilingual labelling (English/French) is common for national distribution, and pharmacies must meet provincial language and Indigenous resource needs where available.

• DIN: Unique identifier assigned by Health Canada to marketed drugs.
• NPN: Not applicable to prescription ketorolac products.
• Product Monograph: Consult for full prescribing and safety information.

Storage & Handling

Standard Canadian Household Conditions

Store tablets and injectable vials at room temperature between 15–25°C and protect from moisture and light.

Do not freeze injectable formulations and keep ampoules in their original packaging until use.

Store all medicines out of reach of children and in a secure place.

Cold‑Chain Requirements

Injectable ketorolac typically does not require refrigeration but avoid exposure to temperature extremes and follow manufacturer handling instructions.

When travelling, carry medication in original packaging with the prescription and provincial health card for identification.

For disposal, use pharmacy take‑back programs rather than household trash or flushing.

Guidelines For Proper Use

Canadian Pharmacist Guidance

Pharmacists should confirm the indication and reconcile concurrent medications, especially anticoagulants, diuretics and ACE inhibitors or ARBs.

Review renal function where available and counsel on the five‑day maximum duration and warning signs for GI bleed and renal dysfunction.

Document counselling and use shared decision‑making with culturally safe communication.

Provincial Health Authority Recommendations

Follow provincial analgesia and perioperative guidelines when dispensing or advising on toradol.

Escalate to the prescriber if therapy beyond five days is requested and consider safer alternatives for chronic pain management.

• Clinician Checklist Before Dispensing: Verify indication and duration.
• Check renal function and anticoagulant status.
• Confirm pregnancy status where applicable.
• Provide written patient information and document counselling.

Delivery Across Canada (English)